MoonLake Immunotherapeutics (MLTX) Sector Health Care
(Current)
$12.00 -0.29 (-2.36%)
Open Price: 12.26
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients